FIELD: medicine, in particular laboratory diagnosis of hemopexis system damage useful in anticoagulant therapy control.
SUBSTANCE: hematocrit is determined in capillary blood of subject; then PT value is twice measured, and mean value is calculated. Said mean value is correlated with PT value of normal plasma and INR is calculated according the formula including coefficient which depends on hematocrit value and International index of thromboplastin reagent sensitivity.
EFFECT: standardized PT value-based method for INR value determination of improved accuracy.
2 cl, 1 tbl, 3 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CONTROLLING THERAPY WITH INDIRECT ANTICOAGULANTS | 2001 |
|
RU2222019C2 |
| MICROFLUID DEVICE AND METHOD OF FLUID CLOTTING TIME DETERMINATION | 2008 |
|
RU2477480C2 |
| METHOD FOR PREDICTING ANTIPHOSPHOLIPID SYNDROME | 2003 |
|
RU2254572C2 |
| METHOD FOR LIQUID CLOTTING TIME DETERMINATION | 2012 |
|
RU2628814C2 |
| METHOD OF ASSESSING RISK OF RECURRENT THROMBOTIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2010 |
|
RU2419800C1 |
| TEST-SYSTEM OF COAGULATION | 2005 |
|
RU2394648C2 |
| EARLY PREDICTION PROCEDURE FOR THROMBOEMBOLIC COMPLICATIONS FOLLOWING ABDOMINAL SURGERIES | 2008 |
|
RU2367350C1 |
| METHOD FOR DIAGNOSING ANTIPHOSPHOLIPID SYNDROME | 1995 |
|
RU2104550C1 |
| METHOD OF MODELING HEMOSTASIS SYSTEM DISORDERS | 2019 |
|
RU2714597C1 |
| DOSAGE FORM OF DNA-APTAMER | 2019 |
|
RU2730000C1 |
